Telehealth Excellence Forum

Telehealth

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Q&As

The Benefits and Challenges of Telehealth for Clinicians and Patients

06/14/2021

Researchers discuss the main takeaways from their recent virtual APA session as well as the primary challenges for both clinicians and patients when utilizing telehealth services.

Researchers discuss the main...

06/14/2021

Psych Congress Network

Videos

Higher Cost of Telehealth Raises Concerns for Future of the Beneficial Treatment Option

06/14/2021

Higher cost of telehealth, compared to in-person treatment, raises concerns that health insurance companies reducing compensation may impact the ability to utilize the treatment.

Higher cost of telehealth,...

06/14/2021

Psych Congress Network

Videos

Effectiveness, Safety Compared Between In-Person and Partial Hospital Treatment

05/18/2021

In this video, Mark Zimmerman, MD, discusses the impetus for his study that found telehealth partial hospital treatment was as effective as in-person treatment.

In this video, Mark Zimmerman,...

05/18/2021

Psych Congress Network

Q&A

Dr. Avrim Fishkind: Moving Beyond the Basics of Telepsychiatry

04/20/2021

A session being presented at the virtual 2021 American Psychiatric Association Annual Meeting will explore equity and ethical issues related to the practice and examine the future of telemedicine, including an array of digital tools.

A session being presented at the...

04/20/2021

Psych Congress Network

Q&As

A Primer on Telehealth and Medical Licensing

04/13/2021

In this installment of "Your Questions Answered," Psych Congress Steering Committee member Edward Kaftarian, MD, responds to questions about your medical license and telehealth.

In this installment of "Your...

04/13/2021

Psych Congress Network

Q&A

Prescribing Controlled Substances When Using Telepsychiatry

12/10/2020

Learn how clinicians can navigate the federal limitation on prescribing controlled substances when treating patients outside of an authorized health care setting.

Learn how clinicians can...

12/10/2020

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Telehealth Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products